0001493152-23-018531.txt : 20230623 0001493152-23-018531.hdr.sgml : 20230623 20230522160530 ACCESSION NUMBER: 0001493152-23-018531 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genenta Science S.p.A. CENTRAL INDEX KEY: 0001838716 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L6 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: OLGETTINA, NO. 58 CITY: MILAN STATE: L6 ZIP: 20132 BUSINESS PHONE: 39-02-2643-6639 MAIL ADDRESS: STREET 1: OLGETTINA, NO. 58 CITY: MILAN STATE: L6 ZIP: 20132 FORMER COMPANY: FORMER CONFORMED NAME: Genenta Science S.r.l. DATE OF NAME CHANGE: 20210104 CORRESP 1 filename1.htm

GENENTA SCIENCE S.P.A.

Olgettina No. 58

20132 Milan, Italy

May 22, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention:

Cindy Polynice

Re:	Genenta Science S.p.A.
	Registration Statement on Form F-3 (File No. 333-271901) filed May 12, 2023.

Requested Date: May 24, 2023

Requested Time: 4:30 PM Eastern Time

Ladies and Gentlemen:

Genenta Science S.p.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form F-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.

The Registrant hereby authorizes Per Chilstrom, who is an attorney with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Chilstrom at (212) 430-2669.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

	Sincerely,

	Genenta Science S.p.A.

	By:	/s/ Pierluigi Paracchi
		Pierluigi Paracchi
		Chief Executive Officer

cc:	Richard B. Slansky, Chief Financial Officer
	Genenta Science S.p.A.

	Per B. Chilstrom, Esq.
	Fenwick & West LLP